| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Carter Todd Alfred serves as a Chief Scientific Officer at VYGR. Across recent SEC filings that breaks down to 0 buys and 18 sells. Those positions are worth an estimated $548K at current prices.
Historically, Carter Todd Alfred's trades have earned a middling insider score of 68/100 across 16 rated trades. Over a 12-month horizon, 78.6% of those trades were profitable, with an average 12-month return of +15.7%.
The biggest single holding is VYGR (~$548K) as Chief Scientific Officer. The recent filings there lean toward selling, a net 52,364 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 24, 2026 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell10b5-1 | 4,174 | $3.76 | $15,694.24 | -2.8% | +1.3% | - | |
| Feb 18, 2026 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell10b5-1 | 3,301 | $3.44 | $11,355.44 | -2.2% | +4.2% | - | |
| Feb 10, 2026 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,525 | $3.85 | $13,571.25 | -2.2% | +11.4% | - | |
| Feb 20, 2025 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,305 | $4.26 | $14,079.30 | -4.1% | -26.1% | -18.1% | |
| Feb 11, 2025 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,413 | $4.45 | $24,087.85 | -6.3% | -20.3% | -13.2% | |
| Jan 14, 2025 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,191 | $5.13 | $6,109.83 | -1.4% | -36.8% | -18.2% | |
| Feb 21, 2024 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 3,967 | $7.50 | $29,759.91 | -4.3% | +10.5% | -44.2% | |
| Jan 17, 2024 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,266 | $7.18 | $9,089.88 | -2.3% | +9.3% | -30.7% | |
| Sep 15, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sale+OE10b5-1 | 10,500 | $8.16 | $85,680.00 | -16.2% | -2.0% | -21.5% | |
| Jul 6, 2023 | VYGR Voyager Therapeutics, Inc. | Chief Scientific Officer | Sell10b5-1 | 5,500 | $10.80 | $59,400.00 | -8.4% | -34.3% | -29.3% |